Change - Announcement of Appointment::Re-designation of Chief Operating Officer to Deputy Chief Executive Officer

Issuer & Securities

Issuer/ Manager
HEALTHWAY MEDICAL CORPORATION LIMITED
Securities
HEALTHWAY MEDICAL CORP LTD - SG1X09940682 - 5NG
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
07-Feb-2020 17:29:35
Status
New
Announcement Sub Title
Re-designation of Chief Operating Officer to Deputy Chief Executive Officer
Announcement Reference
SG200207OTHRV1S4
Submitted By (Co./ Ind. Name)
Raymond Lam Kuo Wei
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
This announcement has been prepared by the Company and its contents have been reviewed by the Company's Sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor") in accordance with Rules 226(2)(b) and 753(2) of the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist.

This announcement has not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or report contained in this announcement.

The contact person for the Sponsor is Ms Gillian Goh, Director, Head of Continuing Sponsorship (Mailing Address: 16 Collyer Quay Income at Raffles, Singapore 049318 and E-mail: sponsorship@ppcf.com.sg).

Additional Details

Date Of Appointment
10/02/2020
Name Of Person
Abram Melkyzedeck Suhardiman
Age
31
Country Of Principal Residence
Singapore
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process)
The Nominating Committee and the Board of Directors ("Board"), having considered the qualification, experience and suitability of Mr Abram Melkyzedeck Suhardiman, is satisfied that Mr Abram Melkyzedeck Suhardiman possesses the requisite qualifications and work experience for the position of Deputy Chief Executive Officer. On the recommendation by the Nominating Committee, the Board approved the re-designation of Mr Abram Melkyzedeck Suhardiman as the Deputy Chief Executive Officer of the Company and its subsidiaries ("Group"). He will relinquish his position as Chief Operating Officer of the Company/Group.
Whether appointment is executive, and if so, the area of responsibility
Executive. Mr Suhardiman continues to be the Executive Director of the Company and he will be re-designated as Deputy Chief Executive Officer of the Company/Group.

Mr Suhardiman will assist the Chief Executive Officer in managing all aspects of the Company and Group's business.
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Executive Director and Deputy Chief Executive Officer
Professional qualifications
Master's Program in Finance, Hult International Business School, San Francisco, CA, USA, 2012

Bachelor of Science in Business Administration, University of Southern California, Los Angeles, CA, USA, 2010
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
Son-in-law of Dr Stephen Riady, the Non-Executive Non-Independent Director of the Company
Conflict of interests (including any competing business)
No
Working experience and occupation(s) during the past 10 years
2019 to Present
Executive Director of the Company

2017 to 2020
Chief Operating Officer of the Company

2015 to 2017
Vice President, Business Development & Investor Relations, Nuvest Capital

2013 to 2015
Analyst, The Abraaj Group

2012 to 2013
Business Development Manager, PT Artha Cipta Langgeng

2010 to 2011
Intern, Citibank N.A.
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
No
Other Principal Commitments* Including Directorships#
*"Principal Commitments" has the same meaning as defined in the Code
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
Nuvest Real Return Fund
Present
City Ocean Group Limited
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Disclosure applicable to the appointment of Director only.
Any prior experience as a director of an issuer listed on the Exchange?
Yes
If Yes, Please provide details of prior experience
Not applicable
Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable)
Not applicable